We are live on
!
Find out more
GP
Girard Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
17.26%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$693M
AUM Growth
+$44M
(+6.8%)
Cap. Flow
+$18.7M
Cap. Flow
% of AUM
2.7%
Top 10 Holdings %
Top 10 Hldgs %
30.22%
Holding
223
New
15
Increased
92
Reduced
96
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.78M |
| 2 |
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
|
+$1.85M |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.74M |
| 4 |
Applied Materials
AMAT
|
+$1.3M |
| 5 |
Roper Technologies
ROP
|
+$956K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$2.53M |
| 2 |
Merck
MRK
|
+$1.52M |
| 3 |
LyondellBasell Industries
LYB
|
+$458K |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$453K |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$438K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.93% |
| 2 | Healthcare | 11.25% |
| 3 | Financials | 11.16% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Communication Services | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Eli Lilly
LLY
$1.08T
| $362K | 0.05% |
1,939
-19
| -1% | -$3.72K |
|
177
Vanguard Dividend Appreciation ETF
VIG
$111B
| $336K | 0.05% |
2,288
-8
| -0.3% | -$1.14K |
|
178
Allstate
ALL
$70.6B
| $334K | 0.05% |
2,908
+137
| +5% | +$15.1K |
|
179
Bristol-Myers Squibb
BMY
$129B
| $329K | 0.05% |
5,211
-1,721
| -25% | -$107K |
|
180
Emerson Electric
EMR
$81.6B
| $329K | 0.05% |
3,653
-512
| -12% | -$44K |
|
181
VF Corp
VFC
$5.92B
| $325K | 0.05% |
4,075
-1,908
| -32% | -$155K |
|
|
XYZ
182
Block Inc
XYZ
$48.9B
| $322K | 0.05% |
1,421
+22
| +2% | +$5.15K |
|
183
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
| $318K | 0.05% |
2,955
-400
| -12% | -$43.2K |
|
184
Vanguard Total International Stock ETF
VXUS
$151B
| $315K | 0.05% |
5,039
-253
| -5% | -$15.9K |
|
185
Oracle
ORCL
$339B
| $314K | 0.05% |
4,478
-301
| -6% | -$19.5K |
|
186
iShares Core S&P Small-Cap ETF
IJR
$109B
| $312K | 0.05% |
2,878
-1,442
| -33% | -$151K |
|
187
TSMC
TSM
$1.94T
| $309K | 0.04% |
2,615
| – | – |
|
188
Linde
LIN
$236B
| $307K | 0.04% |
1,098
-258
| -19% | -$66.9K |
|
189
Ford
F
$60.9B
| $300K | 0.04% |
24,542
-22,687
| -48% | -$260K |
|
190
Deere & Co
DE
$165B
| $288K | 0.04% |
+772
| New | +$253K |
|
191
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
| $283K | 0.04% |
2,432
-3,061
| -56% | -$353K |
|
192
Essential Utilities
WTRG
$11.5B
| $282K | 0.04% |
6,312
+173
| +3% | +$7.81K |
|
193
Realty Income
O
$61.1B
| $278K | 0.04% |
4,523
-414
| -8% | -$24.5K |
|
194
Danaher
DHR
$138B
| $270K | 0.04% |
1,358
-138
| -9% | -$28K |
|
195
iShares Select Dividend ETF
DVY
$23.8B
| $270K | 0.04% |
2,374
+9
| +0.4% | +$951 |
|
|
196
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
| $268K | 0.04% |
3,934
-6,656
| -63% | -$438K |
|
197
Eversource Energy
ES
$28.1B
| $267K | 0.04% |
3,093
| – | – |
|
198
Clorox
CLX
$12B
| $262K | 0.04% |
1,358
-806
| -37% | -$155K |
|
199
General Dynamics
GD
$103B
| $258K | 0.04% |
1,424
-77
| -5% | -$12.6K |
|
200
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
| $251K | 0.04% |
1,932
-453
| -19% | -$60.3K |
|
Similar funds
PO
PRIG
KI
H
RVPG
AC
AT
IFAM
Girard Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Girard Partners held 223 positions worth $693M, up 6.8% from $649M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Girard Partners's Q1 2021 filing shows 15 new, 92 increased, 96 reduced and 8 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 5,719 shares worth $2.71M. The largest sale was Intel, an estimated $2.53M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Girard Partners's largest Q1 2021 buy was Regeneron Pharmaceuticals: 5,719 shares worth $2.71M.
- Girard Partners added most to State Street SPDR Portfolio Aggregate Bond ETF in Q1 2021, an estimated $1.85M increase.
- Girard Partners's biggest Q1 2021 reduction was Intel, cutting an estimated $2.53M.
- Girard Partners fully exited State Street Industrial Select Sector SPDR ETF in Q1 2021, selling an estimated $453K.
- Girard Partners's ten largest holdings make up 30% of its $693M portfolio in Q1 2021.
- Girard Partners opened 15 new positions and closed 8 in Q1 2021.
- Girard Partners's portfolio value rose 6.8% quarter-over-quarter to $693M.
Based on Girard Partners's 13F filing for Q1 2021, filed 6 May 2021.